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Abstract
Background & objectives: Plasmodium falciparum is the leading cause of mortality and causes
cerebral malaria associated with sequestration caused by cytoadherence of the trophozoite and
schizont-infected erythrocytes to the endothelial cells of the deep vascular beds in the brain.
Pathophysiology of malaria is complicated by rosetting. Rosetting is a process of binding of
uninfected erythrocytes to the erythrocytes infected with mature asexual parasites and is controlled
by expression of complement receptor 1 (CR1) on RBC surface. Various polymorphic forms of
CR1 are known including molecular weight polymorphism, red blood cell expression levels/density
polymorphism and Knops (KN) polymorphism. The Knops blood group includes several allelic
pairs; Knops a and b (Kna and Knb), McCoy a and b (McCa, McCb), Swain-Langley (Sla), and
Villien (Vil). Knops phenotype Sl (a–) has been found to rosette less effectively than Sl (a+) and
hence suggested to be more protective. P. falciparum cases have not reduced much as compared to
the reduction in the total number of malaria cases in the past few years. In addition, P. falciparum
is the leading cause for all mortality and most of the morbidity in India. We, therefore, investigated
the role of CR1 Knops polymorphism in the pathophysiology of malaria in Indian population.
Methods: A case control approach was used for this study. CAPS (Cleaved amplified polymorphic
sequence) methodology was adopted.  A total of 100 normal individuals (free from any ailment)
and 100 individuals suffering from P. falciparum infection (uncomplicated malaria) were recruited
for this study.
Results: We found that in Indian population (normal individuals and P. falciparum-infected
individuals), only the wild type allele is present.
Interpretation & conclusion: We concluded that the process of rosetting in the Indian context
could be occurring independently of the effect of Knops polymorphism and in part could be controlled
by other polymorphisms of the CR1 gene (density and structural polymorphism).
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Introduction
Malaria is a disease of poverty and is highly preva-
lent in underdeveloped countries. This disease claims
the life of about 1.5 to 2 million people per year1–2.
Malaria has been a problem in India for centuries.
The annual incidence of malaria was around 75 mil-
lion cases in 1953 with about 0.8 million deaths an-
nually. National Malaria Control Programme and
National Malaria Eradication Programme (1957 and
1958) were a great success and the incidence dropped
to 50,000 cases a year. But malaria staged a dra-
matic comeback in India in the 1970s after its near
eradication3. In recent past (2007 & 2008), malaria
positive cases reported annually from India were 1.5
million, with Plasmodium falciparum proportion 289  GANDHI ET AL: CR1 KNOPS POLYMORPHISM AND MALARIA IN INDIA
being 49% in both 2007 and 2008 from the previ-
ously reported 44% in 20054. Malaria caused by P.
falciparum is a malignant variety of malaria. It has
been reported that infection with P. falciparum is
the most deadly form of malaria. The number of
deaths due to P. falciparum was 963 in 2005 and it
further increased to 1311 in 2007, albeit the deaths
reported in the provisional data for 2008 was found
to be reduced to 9355. But clearly the mortality as-
sociated with malaria is a big problem.
A key feature of the biology of P. falciparum is the
ability of the infected red blood cells to adhere to the
linings of small blood vessels leading to obstruction
of the tissue perfusion. Cerebral malaria is a compli-
cation of severe P. falciparum malaria associated with
cytoadherence of trophozoite and schizont-infected
erythrocytes to endothelial cells of cerebral microvas-
culature. Several receptors including CD366,
thrombospondin7, intercellular adhesion molecule-18,
vascular cell adhesion molecule, and E-selectin9
mediate this interaction. The process of binding of
uninfected erythrocytes to the erythrocytes infected
with mature asexual parasites is called rosetting10.
Complement receptor 1: CR1 (CD35, C3b/C4b re-
ceptor) is a polymorphic membrane bound glycopro-
tein, differentially expressed on erythrocytes, eosi-
nophils, monocytes, B-lymphocytes, T-lymphocytes,
dendritic cells and kidney podocytes11. The major
functions of CR1 are binding to and removal of C4b
and C3b bearing immune complexes, to serve as a
complement regulatory protein12.
Various polymorphic forms of CR1, including mo-
lecular weight polymorphism, red blood cell expres-
sion levels /density polymorphism and Knops (KN)
polymorphism are known. CR1 molecular weight
differs by approximately 30 kilodaltons (kDa), four
different forms are known CR1*1 (220 kDa), CR1*2
(250 kDa), CR1*3 (190 kDa) and CR1*4 (280 kDa),
arising by deletion and duplication of the comple-
ment control proteins (CCPs), mostly contained in
the long homologous repeat-B (LHR-B)13. The CR1
structural variants differ in their number of CCPs/
LHRs and the number of C3b binding sites with small-
est form having one binding site and the largest form
having four sites. In most of the populations studied,
the two most frequent alleles are CR1*1 (220 kDa)
and CR1*2 (250 kDa)14. RBC-CR1 copy number
can vary as much as 10 fold among normal healthy
individuals. RBCs having low levels of CR1 (approxi-
mately 10% of normal) have the serologically null
phenotype known as the ‘Helgeson phenotype’. In
Caucasians, the RBC-CR1 copy number is linked to
a Hind III restriction fragment length polymorphism
(RFLP) called the density polymorphism. It arises
by a single base change in the intron of long homolo-
gous repeat (LHR-D) region within the CR1 gene15.
The Knops blood group localized to the CR1 includes
several presumed allelic pairs; Knops a and b (Kna
and Knb), McCoy a and b (McCa, McCb), Swain-
Langley (Sla), and Villien (Vil)16–18.
Single nucleotide polymorphisms occurring in short
consensus repeat (SCR) 25, which lead to amino acid
substitutions, result in generation of these polymor-
phic forms19. These antigens have been localized on
the LHR-D segment of CR1. The molecular basis of
Kn(a) and Kn(b) polymorphism is the substitution of
Valine in Kn (a+) to Methionine in Kn(b+) at residue
1561. McCa, McCb polymorphism is at 4795 bp,
where A to G transition leads to the substitution of
Proline to Aspartic acid. Sl(a)/Vil mutation is at 4828
bp where, the A to G transition leads to the substitu-
tion of Arginine to Glycine.
The role of Knops polymorphism has been investi-
gated in some disease conditions: leprosy, mycetoma
infection (fungal infection) and malaria to name a
few. In a study published in 2004, homozygotes for
the McCoy b blood group defining variant K1590E
in exon 29 of the complement receptor 1 gene ap-
peared to be protected against leprosy susceptibil-
ity20. In an another study, the allele Sl2 was more
often found in the patients suffering from mycetoma
infection compared to the control subjects, whereas
the McCb allele was more dominant in the control
population. This indicated the possibility of Sl2 and
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mycetoma infection. Knops polymorphism has been
extensively studied in the context of malaria infec-
tion21, but only a limited number of studies are avail-
able on its role in other inflammatory disorders.
Knops polymorphic forms Sl(a–) and McC(b+) have
been found to be present at increased frequency in
the malaria endemic regions22. Knops phenotype
Sl (a–) has been found to rosette less effectively than
Sl (a+) and hence suggested to be more protective23,24.
This observation led the researchers to hypothesize
that the Sl (a–) allele and, possibly, the McCb+ allele
evolved in the context of malaria transmission and
that in certain combinations probably confer a sur-
vival advantage on these populations25. Several stud-
ies have indicated that patients with cerebral malaria
have higher extent of rosette formation compared to
those with mild/uncomplicated malaria26–31. Given
the important role of Knops polymorphic phenotypes
of CR1 in rosetting of RBCs and the fact that this
polymorphism of CR1 has not been studied till date
in the Indian population, we investigated the role of
CR1 Knops polymorphism in the pathophysiology
of malaria in Indian population. This kind of a study
could go a long way in understanding the role of
selective gene pressure in the pathophysiology of
malaria in the context of Indian population. This type
of information could also be helpful in using CR1 as
a target for development of antimalarial vaccine.
Material & Methods
Study subjects: A case control study was undertaken
on two groups of study subjects (100 normal indi-
viduals free from any ailment at the time of collec-
tion of blood sample and 100 individuals suffering
from uncomplicated P. falciparum infection). The
mean age of the normal individuals ranged from
29.14±8.7 yr. Patients with P. falciparum infection
were from the regions of Assam, Gujarat, Madhya
Pradesh, Chennai and Delhi (NCR), where P.
falciparum infection is prevalent. The mean age of
the patients ranges from 30.5±3.2 yr that was com-
parable to those of the normal individuals. Informed
and free consent was taken from normal individuals
and the patients before collection of the blood
samples. The protocol for sample collection was ex-
amined and certified by Biosafety and Ethics Com-
mittee of the participating institutes.
Genomic DNA isolation: DNA from normal healthy
Indian subjects was isolated using the standardized
protocol using EDTA as an anticoagulant. Periph-
eral blood was collected by venipuncture. The plasma
part was separated from the cells by centrifuging at
3500 rpm for 10 min. The cells were immediately
stored at –80°C for isolation of DNA. DNA from
patients infected with P. falciparum was isolated from
the dried blood spots using QIAamp DNA blood Mini
Kit (Qiagen).
Polymerase chain reaction for the amplification of
CR1 gene: For the identification of the Knops geno-
type of the individuals, DNA from the patients and
normal individuals were subjected to amplification
using the primers and the conditions standardized
previously22 with a slight modification in the condi-
tions. PCR was set up in a total of 50 μl volume with
250 ng of genomic DNA, 5 μl of 10X Taq poly-
merase buffer, 0.75 mM of MgCl2 (25 mM), 0.1 mM
each of dNTPs (1 μl of dNTP mix-10 mM each),
0.25 μl of each primer, and 1.25 Units of Taq poly-
merase. The amplification was carried out using the
following conditions: initial denaturation at 95ºC for
5 min, denaturation at 94ºC for 1 min, annealing at
59ºC for 1 min, extension at 72ºC for 1 min for 30
cycles, and a final extension at 72ºC for 10 min in an
MJ, Thermocycler (Perkin Elmer). The product ob-
tained after PCR was 305 bp long.
Restriction digestion: The Knops polymorphic forms
were detected using three enzymes, viz. Nde1, Bsm1
and Mun1. Twenty units each of Nde1, Bsm1, Mun1
were used for the detection of Kna/Knb, McCa/McCb
and Sla/Slb detection respectively. The expected size
of the bands produced after digestion of the PCR
amplified fragment are 261, 44; 166, 139; and 161,
144, respectively for Nde1, Bsm1 and Mun1. Reac-
tion mixture for the detection of each polymorphism
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Fig. 1: (a) The PCR amplified fragments of patients and
normal samples  [Lane 1: Marker DNA, lanes 2–14:
amplified products of CR1 gene in Indian subjects];
(b) Digested fragments of the PCR amplified products
of Indian population [Lane 1: Marker DNA, lanes
1–20: Restriction digests of PCR amplified products
of Indian subjects]; and (c) PCR amplified products
from African individuals [Lane 1: Marker DNA,
lanes 2 and 3: Kna/Kna pattern produced by Nde1
digestion, lanes 4 and 5: McCa/McCb pattern
produced by Bsm1 digestion, lane 6: Observed Sla/
Slb pattern and lane 7: observed Slb/Slb pattern
(African subjects)]
respective enzymes and 10X buffer in different cock-
tails. The reaction mixtures were incubated at 37ºC
overnight. Digestion patterns were analyzed on 2%
agarose gel containing ethidium bromide. The sizes
of the restricted fragments were compared with that
of the marker DNA (Phi-X DNA marker or 100 bp
DNA ladder).
Results
Knops genotyping using polymerase chain reaction
and restriction digestion: DNA samples from 100
normal healthy individuals and 100 patients suffer-
ing from P. falciparum infection were analyzed in
the present study. A single sharp band of length 305
bp was obtained in all the samples for CR1 gene
(Fig. 1a). Upon digestion with Nde1, Bsm1 and
Mun1, the homozygous wild type alleles for Kna,
McCa and Sla were obtained in all the samples
(Fig. 1b).
Restriction digestion of Lambda DNA and DNA from
African individuals: To check for the effects of PCR
components on the activity of enzymes, the diges-
tion pattern of pure Lambda DNA (taken as positive
control of digestion) was analyzed with respect to
Lambda DNA spiked with PCR amplicon in three
different forms: (a) untreated PCR amplicon spiked
with Lambda DNA; (b) salt precipitated PCR
amplicon spiked with Lambda DNA; and (c) column
precipitated PCR amplicon spiked with Lambda
DNA. The reaction mixtures were digested with 20
units of Nde1 and the fragments obtained thereof
were analyzed on agarose gel (Fig. 2). Lambda DNA
produced the desired number of fragments in all the
tubes whereas for the samples, even after using the
salt precipitated and column precipitated amplicons,
only the homozygous form of Knops polymorphism
Fig. 2: Digestion of PCR amplicon spiked with Lambda DNA
[Lane 1: Marker DNA, lane 2: undigested lambda
DNA, lane 3: digested lambda DNA, Digestion of
untreated PCR amplicon spiked with Lambda DNA is
seen in lane 4, lane 5 contains the salt precipitated
PCR amplicon spiked with Lambda DNA and the
pattern of digestion of column precipitated PCR
amplicon spiked with Lambda DNA is obtained in
lane 6]
 (a)
 (b)
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was obtained. This result confirmed that none of the
components of PCR was hindering the enzyme ac-
tivity. To further confirm our results and rule out
any experimental error, the samples obtained from
African individuals (gifted by Dr J.M. Moulds,
Shreveport, U.S.A.) were subjected to amplification
and restriction digestion with Nde1, Bsm1 and Mun1.
When these samples were analyzed for the Knops
polymorphism, the wild type homozygous (Kna/Kna),
homozygous mutant (McCb/McCb) and heterozy-
gous (McCa/McCb and Sla/Slb) forms of the Knops
polymorphism were obtained (Fig. 1c). From the
above results, it was concluded that only the homozy-
gous wild type alleles for Kna, McCa and Sla are present
in the Indian population and it reflects the true pic-
ture of allelic distribution at the Knops locus.
Discussion
In the present study, a total of 100 normal healthy
individuals and 100 patients were genotyped for
Knops polymorphism. All the individuals contained
only the homozygous wild type alleles and the ho-
mozygous mutant type, and the heterozygous forms
of Knops polymorphism were completely absent from
the Indian population. It has already been reported
that the Slb gene is almost completely absent in the
Caucasian and Asian populations32. In Caucasians,
the frequencies of Kna and Knb; McCa and McCb;
and Sla and Slb are 0.99 and 0.01; 0.99 and <0.01;
and 0.99 and <0.01, respectively, thus are in agree-
ment with our observations.
Previously, in a study conducted on Brazilian popu-
lation, the heterozygous Kna/Knb, Sla/Slb and McCa/
McCb individuals were identified only in populations
of European and African descent33.  In an another
study, the frequencies of Kna and Knb, McCa and McCb
and Sla and Slb were 0.98 and 0.02, 0.78 and 0.22,
0.48 and 0.52, respectively in African-American per-
sons. The frequency of Slb was found to be highest
(0.77) in the Bambaran region of Africa. The allele
frequencies of Kna and Knb in the Bandiagara popu-
lation were 0.90 for the Kna allele and 0.10 for Knb
allele22.
From the results obtained in the present study, we
have concluded that only the homozygous wild type
form of the Knops polymorphism is prevalent in the
Indian population and that the process of rosetting
in the Indian context could be occurring indepen-
dently of the effect of Knops polymorphism loci of
CR1. In other words, the rosetting could be medi-
ated by other polymorphisms of the CR1 gene in-
cluding the density and the structural polymorphism.
These two polymorphisms could have a role in in-
creasing the susceptibility to malaria or in providing
resistance against the severity of malaria. It can also
be suggested that the genes for Knb, McCb and Slb
may be under selective pressure in India. It has been
reported previously that false negative results can be
obtained when the RBCs have low CR1 copy num-
ber either owing to an inherited or acquired deficiency
after prolonged storage of the blood samples34. Since
the CR1 levels of the patients or the density poly-
morphism were not determined in the present study,
it could be possible that the density polymorphism is
linked somehow to the absence of Knops polymor-
phism in Indian population. The density and struc-
tural polymorphisms of CR1 gene need to be inves-
tigated in the context of the pathophysiology of
malaria. There is also a need to explore the role of
these polymorphic forms in controlling the process
of rosetting and the severity of malaria. This infor-
mation could be useful for designing the vaccines
against cerebral malaria.
Acknowledgement
We are very thankful to Dr J.M. Moulds, Director,
Clinical Immunogenetics, Life Share Blood Centers,
Shreveport, U.S.A. for providing the DNA samples
from the African individuals. We also thank all the
blood donors who have donated their blood for this
study. The help and grants provided by the Univer-
sity School of Biotechnology, Guru Gobind Singh
Indraprastha University and DST, Delhi are also duly
acknowledged. We would also like to thank techni-
cal staff members of National Institute of Malaria
Research, HQs and the field units for their support
and cooperation during the study. 293  GANDHI ET AL: CR1 KNOPS POLYMORPHISM AND MALARIA IN INDIA
References
1. Kwiatkowski D. Genetic susceptibility to malaria getting
complex. Curr Opin Genet Dev 2000; 10: 320–4.
2. Warrel DA, Molyneux ME, Beales PF. Severe and com-
plicated malaria. Trans R Soc Trop Med Hyg 1990; 84:
1–65.
3. http://www.malariasite.com/malaria/ Malaria in India,
Dr. B.S. Kakkilaya’s Malaria Website, Last Updated: Mar
4, 2008.
4. Malaria situation in India. Delhi: National Vector Borne
Disease Control Programme, Ministry of Health &
Family Welfare, Govt. of India [Available from: http://
nvbdcp.gov.in/Doc/mal-apr-09.pdf].
5. Malaria. Delhi: National Vector Borne Disease Control
Programme, Ministry of Health & Family Welfare, Govt.
of India. [Available from: http://nvbdcp.gov.in/malaria1.
html].
6. Oquendo P, Hundt E, Lawler J, Seed B. CD36 directly
mediates cytoadherence of Plasmodium falciparum
parasitized erythrocytes. Cell 1989; 58:  95–101.
7. Roberts DD, Sherwood JA, Spitalnik SL, Panton LJ,
Howard RJ, Dixit VM, et al. Thrombospondin binds
falciparum malaria parasitized erythrocytes and may me-
diate cytoadherence. Nature 1985; 318: 64–6.
8. Berendt AR, Simmons DL, Tansey J, Newbold CI, Marsh
K. Intercellular adhesion molecule 1 is an endothelial cell
adhesion receptor for Plasmodium falciparum. Nature
1989; 341: 57–9.
9. Ockenhouse CF, Tegosho T, Maeno Y, Benjamin C, Ho
M, Kan KE, et al. Human vascular endothelial cell adhe-
sion receptors for Plasmodium falciparum infected eryth-
rocytes: roles for endothelial leucocytes adhesion molecule
1 and vascular cell adhesion molecule 1. J Exp Med 1992;
176: 1183–9.
10. David PH, Handunnetti SM, Leech JH, Gamage P, Mendis
KN. Rosetting: a new cytoadherence property of malaria
infected erythrocytes. Am J Trop Med Hyg 1988; 38:
289–97.
11. Weiss L, Fisher E, Heaeffner-Cavaillon N, Jouvin MH,
Appay MD, Bariety J, et al. The human C3b receptor
(CR1). Adv Nephrol 1989; 18: 249–69.
12. Ahearn JA, Fearon DT. Structure and function of the
complement receptors CR1 (CD35) and CR2 (CD21). Adv
Immunol 1989; 46: 183–219.
13. Hourcade D, Miesner DR, Bee C, Zeldes W, Atkinson JP.
Duplication and divergence of the amino-terminal cod-
ing region of the complement receptor 1 (CR1) gene. J
Biol Chem 1990; 265(2): 974–80.
14. Cohen JHM, Atkinson JP, Klickstein LB, Oudin S,
Subramanian VB, Moulds JM. The C3b/C4b receptor
(CR1, CD35) on erythrocytes: methods for study of the
polymorphisms. Mol Immunol. 1999; 36(13–14): 819–25.
15. Cornillet P, Philbert F, Kazatchkine MD, Cohen JH. Ge-
nomic determination of the CR1 (CD35) density polymor-
phism on erythrocytes using polymerase chain reaction
amplification and Hind III restriction enzyme digestion.
J Immunol Methods 1991; 136(2): 193–7.
16. Moulds JM, Nickells MW, Moulds JJ, Brown MC,
Atkinson JP. The C3b/C4b receptor is recognized by the
Knops, McCoy, Swain-Langley, and York blood group
antisera. J Exp Med 1991; 173: 1159–63.
17. Rao N, Feguson DJ, Lee SF, Telen MJ. Identification of
human erythrocyte blood group antigens on the C3b/C4b
receptor. J Immunol 1991; 146: 3502–7.
18. Daniels G. Human blood groups. Oxford: Blackwell 1995;
p. 462–3.
19. Gandhi M. Complement receptor 1 and the molecular
pathogenesis of malaria. Indian J Hum Genet 2007; 13:
39–47.
20. Jodene F, Sian F, David KW, Sichali L, Mwaungulu L,
Crampin AC, et al. Large-scale candidate gene study of
leprosy susceptibility in the Karonga district of northern
Malawi. Am J Trop Med Hyg 2004; 71(3): 330–40.
21. van de Sande WW, Fahal A, Verbrugh H, van Belkum A.
Polymorphisms in genes involved in innate immunity
predispose toward mycetoma susceptibility. J Immunol
2007; 179: 3065–74.
22. Moulds JM, Thomas BJ, Doumbo O, Diallo DA, Lyke KE,
Plowe CV, et al. Identification of the Knª/ Knb polymor-
phism and a method for Knops genotyping. Transfusion
2004; 44(2): 164.
23. Krych-Goldberg M, Moulds JM, Atkinson JP. Human
complement receptor type 1 (CR1) binds to a major ma-
larial adhesion. Trends Mol Med 2002; 8(11): 531–6.
24. Cockburn IA, Mackinnon MJ, O’Donnell A, Allen SJ,
Moulds JM, Baisor M, et al. Human complement recep-
tor 1 polymorphism that reduces Plasmodium falciparum
rosetting confers protection against severe malaria. Proc
Nat Acad Sci (USA) 2004; 101 (1): 272–7.
25. Moulds JM, Kassambara L, Middleton JJ, Baby M, Sagara
I, Guindo A, Coulibaly S, et al. Identification of comple-
ment receptor one (CR1) polymorphisms in West Africa.
Genes Immun 2000; 1(5): 325–9.
26. Carlson J, Helmby H, Hill AVS, Brewster D, Greenwood
BM, Wahlgren M. Human cerebral malaria: association
with erythrocyte rosetting and lack of anti-rosetting anti-
bodies. Lancet 1990; 336(8729): 1457–60. J  VECTOR  BORNE  DIS  46, DECEMBER 2009 294
Corresponding author: Dr Monika Gandhi, Lecturer, University School of Biotechnology, Guru Gobind Singh Indraprastha
University, Kashmere Gate, Delhi–110 006, India.
E-mail: monika.gandhi@rediffmail.com
Received: 27 July 2009 Accepted in revised form: 5 October 2009
27. Treutiger CJ, Hedlund I, Helmby H, Carlson J, Jepson A,
Twumasi P, et al. Rosette formation in Plasmodium
falciparum isolates and anti-rosette activity of sera from
Gambians with cerebral or uncomplicated malaria. Am J
Trop Med Hyg 1992; 46(5): 503–10.
28. Ho M, Davis TME, Silamut K, Bunnag D, White NJ.
Rosette formation of Plasmodium falciparum infected
erythrocytes from patients with acute malaria. Infect
Immun 1991; 59(6): 2135–9.
29. Ringwald P, Peron F, Lepers JP, Rabarison P, Rako
tomalala C, Razanamparany M, et al. Parasite virulence
factors during falciparum malaria: rosetting, cytoa
dherence, and modulation of cytoadherence by cytokines.
Infect Immun 1993;  61(12): 5198–204.
30. Kun JFJ, Schmidt-Ott RJ, Lehman LG, Lell B, Luckner
D, Greve B, et al. Merozoite surface antigen 1 and 2 geno-
types and rosetting Plasmodium falciparum in severe and
mild malaria in Lambarene, Gabon. Trans R Soc Trop
Med Hyg 1998; 92(1): 110–4.
31. Rowe A, Obeiro J, Newbold CI, Marsh K. Plasmodium
falciparum rosetting is associated with malaria severity
in Kenya. Infect Immun 1995; 63(6): 2323–6.
32. Zimmerman PA, Fitness J, Moulds JM, McNamara DT,
Kasehagen LJ, Rowe JA, et al. CR1 Knops blood group
alleles are not associated with severe malaria in the
Gambia. Genes Immun 2003; 4: 368–73.
33. Covas DT, de Oliveira FS, Rodrigues ES, Abe-Sandes K,
Silva WA Jr, Fontes AM. Knops blood group haplotypes
among distinct Brazilian populations. Transfusion 2007;
47 (1): 147–53.
34. Moulds JM, Brai M, Cohen J, Cortelazzo A, Cuccia M,
Lin M, et al. Reference typing report for complement re-
ceptor 1 (CR1). Exp Clin Immunogenet 1998; 15(4):
291–4.